Internal Medicine, Pulmonary Disease · Middletown, NY
NPI
1619960630
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
155 Crystal Run Rd
Middletown, NY, 10941
Phone (845) 703-6999
Groups this clinician bills Medicare through
Medicare paid, 2024
$195K
2,680 services
Medicare patients, 2024
701
Average age 73
Drug cost, 2024
$1.6M
4,953 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ali Hmidi was code 99214 (office e&m - established), 812 times for 440 patients. In total Ali Hmidi billed 2,680 services in 48 codes, and Medicare paid $195K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 812 | 440 | $98.84 | $80K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 447 | 362 | $13.84 | $6,186 |
| 99232 Hospital E&M - Subsequent | Facility | 277 | 141 | $65.54 | $18K |
| 99233 Hospital E&M - Subsequent | Facility | 165 | 134 | $98.66 | $16K |
| G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 151 | 74 | $29.32 | $4,428 |
| 99222 Hospital E&M - Initial | Facility | 133 | 122 | $108.75 | $14K |
| 99213 Office E&M - Established | Office | 92 | 86 | $67.92 | $6,249 |
| 99204 Office E&M - New | Office | 85 | 85 | $128.99 | $11K |
| 99215 Office E&M - Established | Office | 83 | 68 | $141.48 | $12K |
| J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 69 | 23 | $0.04 | $2.58 |
| 94729 Pulmonary Function Testing | Office | 50 | 50 | $49.29 | $2,465 |
| 94726 Pulmonary Function Testing | Office | 49 | 49 | $48.65 | $2,384 |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 36 | 35 | $80.22 | $2,888 |
| 99223 Hospital E&M - Initial | Facility | 35 | 34 | $144.62 | $5,062 |
| 94060 Pulmonary Function Testing | Office | 31 | 31 | $28.10 | $871 |
By year: 2022 $212K for 2,531 services; 2023 $224K for 2,607 services; 2024 $195K for 2,680 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 18 | 14 | $8.65 | $156 |
Medicare prescription drug claims, 2024
In 2024, the drug Ali Hmidi prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 902 prescriptions and refills. In total Ali Hmidi wrote 4,953 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 902 | 989 | 337 | $25K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 618 | 712 | 199 | $450K |
| Montelukast Sodium Generic | 530 | 1,040 | 153 | $3,997 |
| Prednisone Generic | 426 | 479 | 176 | $1,580 |
| Breo Ellipta Fluticasone/Vilanterol | 341 | 417 | 98 | $165K |
| Incruse Ellipta Umeclidinium Bromide | 340 | 477 | 90 | $163K |
| Ipratropium Bromide Generic | 300 | 346 | 121 | $6,761 |
| Fluticasone Propionate Generic | 162 | 246 | 67 | $2,783 |
| Symbicort Budesonide/Formoterol Fumarate | 140 | 193 | 48 | $45K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 118 | 160 | 42 | $15K |
| Advair Hfa Fluticasone Propion/Salmeterol | 101 | 143 | 27 | $54K |
| Spiriva Handihaler Tiotropium Bromide | 95 | 153 | 25 | $77K |
| Roflumilast Generic | 78 | 95 | 14 | $6,809 |
| Ventolin Hfa Albuterol Sulfate | 69 | 71 | 21 | $3,948 |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 69 | 76 | 21 | $38K |
Brand drugs: - claims; generic drugs: 2,490 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ali Hmidi were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.